From Sentinels to Soldiers: Tissue-Resident Cells for Next-Generation Immunotherapy

Area of Science:

• Immunology
• Cellular Biology
• Cancer Immunology

Background:

• Tissue-resident immune cells survey peripheral tissues, mediating durable antitumor immunity.
• This residency principle extends beyond CD8+ T cells to CD4+ T cells, NK cells, and myeloid populations.
• Understanding tissue residency is critical for developing effective immunotherapies.

Purpose of the Study:

• To provide an integrative framework for tissue-resident biology, from development to therapeutic applications.
• To explore the role of tissue niches and metabolic adaptations in tissue-resident cell differentiation.
• To examine tumors as pathological niches and the implications for immunotherapy.

Main Methods:

• Review of existing literature on tissue-resident immune cells.
• Framework development for understanding tissue residency ontogeny and niches.
• Analysis of metabolic factors influencing tissue residency.
• Examination of tumor microenvironments as non-canonical niches.

Main Results:

• Tissue-resident cell differentiation is shaped by priming signals and tissue niche interactions.
• Metabolic adaptations like fatty acid oxidation and hypoxic specialization are key to tissue residency.
• Tumors preserve tissue retention mechanisms but often lose effector identity.
• Tissue-resident T cells are critical for immunosurveillance and response to checkpoint blockade.

Conclusions:

• Integrating tissue-residency principles into immunotherapy is essential for durable responses in solid tumors.
• Further research into tissue-resident cell biology can optimize cellular immunotherapy manufacturing and efficacy.
• Tissue residency represents a fundamental aspect of peripheral immunity with broad therapeutic potential.